muramyl tripeptide phosphatidyl ethanolamine Report issue

Small molecule Experimental
AACT ChEMBL Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC
  • InChIKey: JMUHBNWAORSSBD-WKYWBUFDSA-N
  • Mol. Mass: 1237.52
  • ALogP: Missing data
  • ChEMBL Molecules:
    mifamurtide  
    mifamurtide  
More Chemistry

Pharmacology

Alternative names

cgp 19835 a | cgp-19835a | junovan | l-alaninamide, n-(n-acetylmuramoyl)-l-alanyl-d-alpha-glutaminyl-n-(4-hydroxy-10-oxo-7-((1-oxohexadecyl)oxy)-3,5,9-trioxa-4-phosphapentacos-1-yl)-, p-oxide, (r)- | l-mtp-pe | mepact | mifamurtide | mifamurtide acid | mifamurtide anhydrous | mifamurtide free acid anhydrous | mifamurtide hydrate | mifamurtide sodium | mifamurtide sodium hydrate | mifamurtide sodium salt | mlv 19835 | mtp-pe | muramylnac-ala-isogln-lys-tripeptide-pe | muramylnac-ala-isogln-lys-tripeptide-phosphatidylethanolamine | muramyl tripeptide-1,2-dipalmitoylphosphatidylethanolamine conjugate | muramyl tripeptide-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine conjugate | muramyl tripeptide phosphatidylethanolamine | muramyl tripeptide phosphatidyl ethanolamine | muramyl tripeptide phosphatidylethanolamine, monosodium salt | muramyl tripeptide phosphatidylethanolamine, sodium salt | n-acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethanolamine

Organizations (10)

Research & Development (10)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

HIV Infections (Phase 1)

Osteosarcoma (Phase 2/Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial Organizations: 10

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue